Find uplifting stories about heroes, innovations, and solutions
1165 results for "chronic migraine"
A Brazilian study found that ear acupuncture helped reduce migraine pain by up to 18% in women suffering from chronic attacks. The research offers hope for the millions who struggle to find relief from conventional treatments alone.
A breakthrough study shows that Botox injections significantly reduced chronic migraines in children and teens, offering hope where treatment options have been scarce. One in three young patients experienced at least 50% fewer headache days after just two treatments.
A migraine prevention drug just passed a major test for patients who haven't found relief from existing treatments. After 12 weeks, the intravenous antibody significantly reduced monthly migraine days compared to placebo.
A biotechnology company has developed elismetrep, a novel drug that works differently from existing migraine treatments and could help the 70% of patients who don't find relief with current options. The drug targets a previously unexplored pathway in pain neurons, offering new hope for millions of migraine sufferers.
Stanford researchers used brain imaging to identify two biological subtypes of migraine headaches, a breakthrough that could end the guesswork in treating one of the world's leading causes of disability. The discovery may help millions of patients get the right treatment from day one.
Revolutionary new treatments are transforming life for the billion people worldwide who suffer from migraine. From nerve-stimulating devices to breakthrough medications, patients finally have real options after decades of limited relief.
A Buddhist meditation teacher who developed chronic illness from black mold exposure discovered how mindfulness and hypnosis can rewire the brain to help people suffering from ongoing health conditions. Her personal journey is now helping others find hope and healing.
A breakthrough treatment reduces migraine frequency by nearly twice as much as a placebo in children and adolescents, offering hope to young people who've had limited medical options. Almost half of kids using the drug saw their migraine days cut in half.
For 50 million Americans living with chronic pain that drugs can't touch, Virginia Tech researchers just delivered groundbreaking news: they've reversed persistent pain in mice by targeting a previously overlooked biological pathway. The discovery could lead to the first new non-opioid chronic pain treatment in years.
A common blood pressure medication helped mice recover from migraine symptoms by boosting the brain's natural cleaning system. The discovery could offer new hope for the one in three migraine patients who don't respond to current treatments.
A groundbreaking UC San Diego study proves low-dose cannabis effectively treats acute migraines, with two-thirds of patients experiencing pain relief within two hours. The placebo-controlled trial offers hope for millions seeking alternatives to traditional migraine medications.
Scientists discovered a brain circuit that drives chronic pain separately from protective acute pain, opening the door to treatments that could help 60 million Americans without dulling their danger responses. When researchers silenced this circuit in mice, chronic pain disappeared while normal pain signals stayed intact.
Scientists are revisiting an old pathway for migraine treatment that could help the 1 in 3 patients who don't respond to current medications. New research shows blocking substance P, a pain-triggering molecule, might unlock relief for hundreds of millions of people worldwide.
Scientists at Virginia Tech have reversed chronic pain in mice by blocking a single enzyme pathway, offering hope for 50 million Americans whose pain doesn't respond to current treatments. The discovery could lead to the first new class of non-opioid pain relief in years.
Virginia Tech researchers have successfully reversed chronic pain in mice by blocking a single enzyme pathway, offering hope for 50 million Americans whose pain doesn't respond to current treatments. The breakthrough targets a biological mechanism previously overlooked by conventional painkillers.
A small clinical trial reveals that ketamine, already used for depression, may offer rapid energy relief to millions suffering from chronic fatigue. The findings give hope to patients who've exhausted all other options.
After a decade of daily antihistamines and debilitating migraines, Priya Vijan switched to plant-based eating and watched her symptoms vanish. Her healthy recipes just earned her a spot on MasterChef India 2023.
Researchers have identified the genetic fingerprint of "sleeping" pain neurons that affect 10% of people with chronic nerve pain. This breakthrough opens the door to targeted treatments that could silence overactive pain signals without affecting normal sensation.
A supplement already sitting in millions of medicine cabinets might work as well as prescription painkillers for chronic pain. University of Sydney researchers found melatonin reduced pain by the same amount as opioids and NSAIDs in over 2,000 patients.
People with long Covid, POTS, and other chronic conditions are using fitness trackers to avoid debilitating crashes and reclaim their lives. After three years of tracking her health data, one journalist went from bedridden episodes to living crash-free.
Showing 20 of 1165